The present invention relates to the pyrrolidine substituted with flavone derivatives represented by the compounds of Formula (I) (as described herein) or pharmaceutically acceptable salts solvates stereoisomers or diastereoisomers thereof or pharmaceutical compositions containing the compounds of Formula (I) for use in the prevention and/or treatment of oral mucositis caused by cancer therapy such as radiation therapy.